Several women featured in reporting describe continuing to use Mounjaro (tirzepatide) for weight loss even after experiencing unwanted side effects, including effects they say leave them embarrassed and have financial costs. One account focuses on a user who highlights ongoing difficulties and the effort involved in managing visible changes.
The articles present a personal, experience-led view, emphasizing motivation to lose weight and the decision to keep using the medication despite negative outcomes. The framing across the two versions is closely aligned, with both outlining similar details and story structure rather than providing comparative medical analysis. Neither outlet’s excerpt offers additional evidence on prevalence, severity across broader populations, or long-term outcomes, focusing instead on individual narratives and the perceived trade-offs. The accounts also do not detail specific clinical guidance cited in the excerpt, such as prescriber recommendations for managing the side effects.
